INSL4 - insulin like 4 Gene

Homo sapiens

Also known as EPIL; PLACENTIN

Gene ID: 3641 | Gene type: protein coding

About INSL4

Cytogenetic location: 9p24.1 Genomic coordinates (GRCh38): 9:5,231,419-5,235,304 (from NCBI)

This gene has 1 transcript (splice variant), 64 orthologues and 3 paralogues. Restricted expression toward placenta (RPKM 30.0).

Summary

INSL4 encodes the insulin-like 4 protein, a member of the Insulin superfamily. INSL4 encodes a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. Expression of INSL4 products occurs within the early placental cytotrophoblast and syncytiotrophoblast. [provided by RefSeq, Jul 2008]

INSL4 Products(1)

mRNA	Protein	Name
NM_002195.2	NP_002186.1	early placenta insulin-like peptide precursor

Protein Preferred Names

Protein Names

early placenta insulin-like peptide

early placenta insulin-like peptide (EPIL)

Recombinant INSL4 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P70833	INSL4 Protein, Human (HEK293, His)	Q14641 (A26-T139)	≥95%

Related Diseases

Diseases

Alias

Placenta Accreta

Chromosome 9p Deletion Syndrome

Monosomy 9p	Monosomy 9p Syndrome
Alfi Syndrome	9p Syndrome
Chromosome 9p Deletion	9p Deletion
9p Monosomy	Deletion 9p
Partial Monosomy 9p	9p Deletion Syndrome
9p- Syndrome	Alfi'S Syndrome
Chromosome 9, Partial Trisomy 9p

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Pre-clinical Phase

Bioactive Molecules (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-RS06841	INSL4 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown

Name
Email *

	Sorry, but the email address you supplied was invalid.